Published in Heart Lung Vessel on January 01, 2015
Renal protection in cardiovascular surgery. F1000Res (2016) 0.75
Acute kidney injury-an overview of diagnostic methods and clinical management. Clin Kidney J (2017) 0.75
Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail (2013) 4.42
Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med (2008) 3.50
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA (2007) 2.90
Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med (2012) 2.47
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Am J Cardiol (2006) 2.37
[Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol (2006) 2.26
[The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome]. Rev Esp Cardiol (2008) 2.22
Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med (2010) 2.22
Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure. Eur J Heart Fail (2005) 2.17
The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg (2007) 1.97
Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail (2007) 1.91
Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth (2009) 1.84
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med (2005) 1.83
Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. Am J Cardiol (2004) 1.83
Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study. Crit Care Med (2013) 1.64
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. Crit Care Med (2011) 1.56
Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine. Cardiovasc Drugs Ther (2007) 1.53
[Hemodynamic effects of levosimendan following cardiac surgery]. Rev Esp Anestesiol Reanim (2005) 1.46
Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol (2006) 1.31
Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study. Crit Care (2010) 1.26
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol (2011) 1.24
Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Med (2012) 1.01
Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. J Cardiothorac Vasc Anesth (2010) 0.98
Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs. J Pharmacol Exp Ther (2012) 0.91
Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study. J Cardiovasc Pharmacol (2004) 0.90
Reducing mortality in acute kidney injury patients: systematic review and international web-based survey. J Cardiothorac Vasc Anesth (2013) 0.90
Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation. J Card Fail (2007) 0.89
A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail (2001) 0.89
Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J Cardiothorac Vasc Anesth (2006) 0.89
Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med (2001) 0.88
Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure. Atherosclerosis (2007) 0.87
Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol (1999) 0.86
Levosimendan in aortic valve surgery: cardiac performance and recovery. J Cardiothorac Vasc Anesth (2008) 0.86
Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. Int J Cardiol (2011) 0.85
Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol (2006) 0.84
Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Br J Pharmacol (1996) 0.84
The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study. Interact Cardiovasc Thorac Surg (2007) 0.84
Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis. J Cardiovasc Pharmacol (2014) 0.83
Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival. J Cardiovasc Pharmacol (2012) 0.82
Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig. J Cardiovasc Pharmacol (2005) 0.81
Renal effects of levosimendan: a consensus report. Cardiovasc Drugs Ther (2013) 0.80
Levosimendan improves renal outcome in cardiac surgery: a randomized trial. J Cardiothorac Vasc Anesth (2014) 0.80
Effects of levosimendan on indocyanine green plasma disappearance rate and the gastric mucosal-arterial pCO2 gradient in abdominal aortic aneurysm surgery. Acta Anaesthesiol Scand (2008) 0.79
Effects of levosimendan on renal function in patients undergoing coronary artery surgery. J Cardiothorac Vasc Anesth (2012) 0.79
Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction. Cardiovasc Ther (2013) 0.78
Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure. Arq Bras Cardiol (2010) 0.77
Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure. Heart Vessels (2010) 0.77
Barotrauma in Coronavirus Disease 2019 Patients Undergoing Invasive Mechanical Ventilation: A Systematic Literature Review. Crit Care Med (2022) 1.38
Additive Effect on Survival of Anaesthetic Cardiac Protection and Remote Ischemic Preconditioning in Cardiac Surgery: A Bayesian Network Meta-Analysis of Randomized Trials. PLoS One (2015) 0.93
Dexmedetomidine reduces the risk of delirium, agitation and confusion in critically Ill patients: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth (2014) 0.89
The attractiveness of network meta-analysis: a comprehensive systematic and narrative review. Heart Lung Vessel (2015) 0.85
A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design. Am Heart J (2016) 0.78
Prevention of organ dysfunction in septic shock: still looking for an effective treatment. J Thorac Dis (2016) 0.75
Effect of Levosimendan Treatment in Pediatric Patients With Cardiac Dysfunction: An Update of a Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Cardiothorac Vasc Anesth (2021) 0.75
Colloids Versus Crystalloids: Is That the Real Problem? J Cardiothorac Vasc Anesth (2016) 0.75
Nonsurgical Strategies to Reduce Mortality in Patients Undergoing Cardiac Surgery: An Updated Consensus Process. J Cardiothorac Vasc Anesth (2017) 0.75
A Systematic Review and International Web-Based Survey of Randomized Controlled Trials in the Perioperative and Critical Care Setting: Interventions Increasing Mortality. J Cardiothorac Vasc Anesth (2019) 0.75
Nuclear DNA as Predictor of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft: A Pilot Study. J Cardiothorac Vasc Anesth (2017) 0.75
Randomized Evidence for Reduction of Perioperative Mortality: An Updated Consensus Process. J Cardiothorac Vasc Anesth (2016) 0.75
Blood purification with continuous venovenous hemofiltration in patients with sepsis or acute respiratory distress syndrome. A systematic review and meta-analysis of randomized evidence. Minerva Anestesiol (2017) 0.75
An innovative technique to improve safety of volatile anesthetics suction from the cardiopulmonary bypass circuit. Ann Card Anaesth (2017) 0.75
Perioperative levosimendan in cardiac surgery: A systematic review with meta-analysis and trial sequential analysis. Int J Cardiol (2017) 0.75
Kounis syndrome due to antibiotics: A global overview from pharmacovigilance databases. Int J Cardiol (2016) 0.75
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights. J Cardiothorac Vasc Anesth (2016) 0.75
Meta-analyses on Vitamin D in critically ill patients: What data can tell us. J Crit Care (2017) 0.75